Sevelamer hydrochloride versus calcium salts as phosphate binder in chronic kidney disease: A systematic review

被引：0
作者：
Navaneethan, SD
Chaukiyal, P
Craig, J
Strippoli, GFM
机构：
[1] Unity Hlth Syst, Rochester, NY USA
[2] Cochrane Renal Grp, Sydney, NSW, Australia
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2006年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
115
引用
收藏
页码：A47 / A47
页数：1
相关论文
共 50 条
  • [41] Practice patterns of phosphate binder use and their associations with mortality in chronic kidney disease
    Navaneethan, Sankar D.
    Sakhuja, Ankit
    Arrigain, Susana
    Sharp, John
    Schold, Jesse D.
    Nally, Joseph V., Jr.
    CLINICAL NEPHROLOGY, 2014, 82 (01) : 16 - 25
  • [42] CHRONIC KIDNEY DISEASE Phosphate binder therapy-cracks in the tower of strength?
    Evenepoel, Pieter
    Meijers, Bjorn
    NATURE REVIEWS NEPHROLOGY, 2012, 8 (11) : 615 - 616
  • [43] Evaluating Sucralfate as a Phosphate Binder in Normal Cats and Cats with Chronic Kidney Disease
    Quimby, Jessica
    Lappin, Michael
    JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION, 2016, 52 (01) : 8 - 12
  • [44] Calcium-based phosphate binders and chronic kidney disease
    Hiremath, Swapnil
    Akbari, Ayub
    LANCET, 2014, 383 (9913) : 216 - 216
  • [45] Pathophysiology of Calcium and Phosphate Metabolism Impairment in Chronic Kidney Disease
    Cozzolino, Mario
    Ciceri, Paola
    Volpi, Elisa Maria
    Olivi, Laura
    Messa, Pier Giorgio
    BLOOD PURIFICATION, 2009, 27 (04) : 338 - 344
  • [46] Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression
    Kuro-o, Makoto
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2023, 32 (04) : 344 - 351
  • [47] A balanced view of calcium and phosphate homeostasis in chronic kidney disease
    Evenepoel, Pieter
    Wolf, Myles
    KIDNEY INTERNATIONAL, 2013, 83 (05) : 789 - 791
  • [48] Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease
    Habbous, Steven
    Przech, Sebastian
    Martin, Janet
    Garg, Amit X.
    Sarma, Sisira
    VALUE IN HEALTH, 2018, 21 (03) : 318 - 325
  • [49] A SPANISH COST-EFFECTIVENESS ANALYSIS OF SEVELAMER VERSUS CALCIUM CARBONATE IN NONDIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (CKD) PATIENTS
    Subira, R.
    Rubio, M.
    Rodriguez-Carmona, A.
    Pons, R.
    del Pino, M. D.
    VALUE IN HEALTH, 2014, 17 (07) : A470 - A470
  • [50] RANDOMIZED CONTROLLED TRIAL COMPARING THE EFFICACY OF SEVELAMER VERSUS CALCIUM ACETATE IN CHILDREN WITH CHRONIC KIDNEY DISEASE STAGE III-IV
    Gulati, Ashima
    Sridhar, Vijesh
    Hari, Pankaj
    Bagga, Arvind
    PEDIATRIC NEPHROLOGY, 2009, 24 (03) : 672 - 672
12345